ES2156868T3 - Compuestos de arilalcoxifenoxi-imidazolina. - Google Patents

Compuestos de arilalcoxifenoxi-imidazolina.

Info

Publication number
ES2156868T3
ES2156868T3 ES93903073T ES93903073T ES2156868T3 ES 2156868 T3 ES2156868 T3 ES 2156868T3 ES 93903073 T ES93903073 T ES 93903073T ES 93903073 T ES93903073 T ES 93903073T ES 2156868 T3 ES2156868 T3 ES 2156868T3
Authority
ES
Spain
Prior art keywords
arilalcoxifenoxi
imidazoline compounds
imidazoline
compounds
arylalkoxyphenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903073T
Other languages
English (en)
Inventor
Jules Freedman
Bruce M Baron
Mark W Dudley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/832,556 external-priority patent/US5216008A/en
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2156868T3 publication Critical patent/ES2156868T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Reinforced Plastic Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)

Abstract

LA PRESENTE INVENCION TIENE POR OBJETO UNA NUEVA CLASE DE COMPUESTOS DE ARILALKOXIFENOXI, Y SU USO PARA EL TRATAMIENTO DE DEPRESION, ANSIEDAD, HIPERTENSION Y DOLORES DE CABEZA COMO JAQUECAS
ES93903073T 1992-02-06 1993-01-12 Compuestos de arilalcoxifenoxi-imidazolina. Expired - Lifetime ES2156868T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/832,556 US5216008A (en) 1992-02-06 1992-02-06 Arylalkoxyphenoxy-imidazoline compounds
US99017492A 1992-12-24 1992-12-24

Publications (1)

Publication Number Publication Date
ES2156868T3 true ES2156868T3 (es) 2001-08-01

Family

ID=27125545

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903073T Expired - Lifetime ES2156868T3 (es) 1992-02-06 1993-01-12 Compuestos de arilalcoxifenoxi-imidazolina.

Country Status (19)

Country Link
US (1) US5407954A (es)
EP (1) EP0625969B1 (es)
JP (1) JPH07504167A (es)
KR (1) KR100276994B1 (es)
AT (1) ATE199547T1 (es)
CA (1) CA2129142A1 (es)
DE (1) DE69329994T2 (es)
DK (1) DK0625969T3 (es)
ES (1) ES2156868T3 (es)
FI (1) FI943637A0 (es)
GR (1) GR3035915T3 (es)
HU (1) HUT67527A (es)
IL (2) IL104600A0 (es)
MX (1) MX9300601A (es)
NO (1) NO304597B1 (es)
NZ (1) NZ246823A (es)
PT (1) PT625969E (es)
TW (1) TW366338B (es)
WO (1) WO1993016051A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0408470A1 (en) * 1989-07-06 1991-01-16 Eastman Kodak Company Maleated polypropylene blends for melt-bonding applications
CA3025884C (en) 2016-06-24 2023-03-07 Ohio University Glucose transport inhibitors and methods of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695555A1 (de) * 1967-02-23 1970-07-16 Nordmark Werke Gmbh Neue Aryloxy-isoalkyl-delta2-imidazoline und deren Saeureadditionssalze sowie Verfahren zu ihrer Herstellung
CA2027530C (en) * 1989-10-20 2001-05-08 Jules Freedman W-phenoxy-heterocyclic compounds

Also Published As

Publication number Publication date
NO942917D0 (es) 1994-08-05
HUT67527A (en) 1995-04-28
US5407954A (en) 1995-04-18
GR3035915T3 (en) 2001-08-31
TW366338B (en) 1999-08-11
HU9402283D0 (en) 1994-10-28
DE69329994D1 (en) 2001-04-12
ATE199547T1 (de) 2001-03-15
NO942917L (no) 1994-08-05
AU3442293A (en) 1993-09-03
DE69329994T2 (de) 2001-06-28
JPH07504167A (ja) 1995-05-11
EP0625969B1 (en) 2001-03-07
IL104600A0 (en) 1993-06-10
MX9300601A (es) 1993-08-01
NZ246823A (en) 1996-06-25
EP0625969A1 (en) 1994-11-30
CA2129142A1 (en) 1993-08-19
WO1993016051A1 (en) 1993-08-19
DK0625969T3 (da) 2001-04-30
FI943637A (fi) 1994-08-05
KR950700260A (ko) 1995-01-16
PT625969E (pt) 2001-08-30
KR100276994B1 (ko) 2002-06-20
IL122537A0 (en) 1998-06-15
FI943637A0 (fi) 1994-08-05
NO304597B1 (no) 1999-01-18
AU671270B2 (en) 1996-08-22

Similar Documents

Publication Publication Date Title
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
SE9502893L (sv) Användning av kollagenas
DE69534908D1 (de) Verwendung von statin zur behandlung von hauterkrankungen
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
DK0406211T3 (da) Fucosidase-inhibitorer
NO984245D0 (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
ES2156868T3 (es) Compuestos de arilalcoxifenoxi-imidazolina.
ATE267209T1 (de) Reinigung von carboxaldehyd
DK1019347T3 (da) Fremgangsmåde til syntesen af taxaner
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
MX9706424A (es) Uso de la moxonidina para el tratamiento de la aterosclerosis.
UA40497A (uk) Спосіб лікування генералізованого катарального гінгівіту
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 625969

Country of ref document: ES